港股收評:全線飆升!恒生科技指數大升5.56%,AI醫療、影視表現活躍
今日,恒生科技指數大升5.56%升勢最為搶眼,恒生指數、國企指數分別上升3.69%、4.11%。

盤面上,大型科技股集體大升,小米再創歷史新高。
阿里巴巴-W收升6.34%,報124.1港元,股價創2022年1月以來新高,本週累升24.1%,月內累升超40%。
嗶哩嗶哩升超14%,騰訊、京東、快手升超7%,美團升超6%,百度升超2%。

AI醫療、AI應用等方面全線攀升,亞信科技一度飆升近40%,阿里健康大升超29%,醫渡科技、微盟集團、金山軟件等齊升;哪吒2帶火行業,影視娛樂股持續上升,阿里影業升12.5%續創均刷新高;大金融股、生物醫藥股、汽車股、教育股、內房股、光伏股、餐飲股紛紛上升。
另一方面,豬肉概念股龍頭萬洲國際逆勢下跌2.3%,半導體股、石油股部分走低,華虹半導體績後跌2.47%,中芯國際跌近1%,中海油、中石化飄綠。
此外,仍有近30只細價股跌幅超10%,順風清潔能源大跌超33%跌幅居首。
具體來看:
互聯網醫療板塊狂飆,阿里健康升超29%,眾安在線升超20%,平安好醫生升超17%,叮噹健康升超15%,京東健康升超7%。

消息上,華為將發佈基於華為DCS AI解決方案打造的瑞金病理模型。國金證券指出,AI賦能在線問診和健康管理,線上醫療效率與質量雙優化。
影視股連續上升,阿里影業升超12%,IMAX中國升超4%,貓眼娛樂、檸萌影視升超2%。

燈塔專業版數據顯示,截至2月13日19時11分,《哪吒2》總票房(含預售)已突破100億元,這是中國第一部票房成績突破百億元大關的電影。
鋰電池板塊表現活躍,比亞迪股份升超7%,比亞迪電子升超5%,贛鋒鋰業、天齊鋰業升超3%。

汽車股大升,比亞迪股份、長城汽車升超7%,小鵬汽車、蔚來升超5%,吉利汽車、零跑汽車升超4%,理想汽車、恒大汽車、華晨中國升超3%,廣汽集團、北京汽車升超2%。

教育股上升,新東方-S升超6%,網龍升近5%,東方甄選升超2%。

電信股普升,中國聯通、中國電信升超5%,中國通信服務、中國移動、中信國際電訊、數碼通電訊升超2%。

內房股上升,世茂集團升超6%,中國海外發展升超5%,雅居樂集團、融信中國升超4%,華潤置地、建發國際集團、龍光集團升超3%。

半導體板塊走勢分化,華虹半導體跌超2%,貝克微跌超1%,中芯國際微跌,英諾賽科升超6%,上海復旦升超2%,晶門半導體、宏光半導體升超1%。


石油股下跌,中國油氣控股跌超7%,中國石油化工股份、中國海洋石油微跌。

今日,南向資金淨買入77.13億港元,其中港股通(滬)淨買入40.43億港元,港股通(深)淨買入36.7億港元。

展望未來,中信證券認為,全年來看,在國內經濟基本面逐步復甦的背景下,疊加估值的性價比,依舊看好港股延續2024年以來的反轉行情。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.